Savaria Co. (TSE:SIS – Get Free Report) insider Jean-Philippe De Montigny sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, September 21st. The stock was sold at an average price of C$29.21, for a total transaction of C$292,100.00. Following the completion of the sale, the insider directly owned 82,560 shares in the company, valued at C$2,411,577.60. This represents a 10.80% decrease in their ownership of the stock.
Savaria Price Performance
Shares of Savaria stock opened at C$29.40 on Friday. The business’s fifty day moving average price is C$29.16 and its 200 day moving average price is C$28.71. Savaria Co. has a twelve month low of C$20.10 and a twelve month high of C$31.95. The company has a current ratio of 1.72, a quick ratio of 0.91 and a debt-to-equity ratio of 29.43. The stock has a market capitalization of C$2.12 billion, a P/E ratio of 24.30, a PEG ratio of 42.72 and a beta of 0.97.
Savaria (TSE:SIS – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported C$0.35 earnings per share (EPS) for the quarter. The company had revenue of C$245.78 million during the quarter. Savaria had a net margin of 9.27% and a return on equity of 13.41%. As a group, research analysts anticipate that Savaria Co. will post 1.2048518 earnings per share for the current year.
Analyst Ratings Changes
Get Our Latest Stock Report on Savaria
About Savaria
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Further Reading
- Five stocks we like better than Savaria
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
